1,433 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Oak Thistle LLC

Oak Thistle LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 1,433 shares of the biotechnology company’s stock, valued at approximately $852,000.

Other institutional investors have also modified their holdings of the company. Insigneo Advisory Services LLC boosted its holdings in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares during the period. Menard Financial Group LLC boosted its stake in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the period. PFG Investments LLC grew its position in shares of Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after buying an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC increased its stake in shares of Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after buying an additional 26 shares during the period. Finally, Mather Group LLC. raised its holdings in Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after acquiring an additional 27 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by company insiders.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $580.00 on Thursday. The stock has a market capitalization of $44.23 billion, a price-to-earnings ratio of 149.87, a PEG ratio of 14.19 and a beta of 1.04. The firm’s fifty day simple moving average is $612.80 and its 200-day simple moving average is $454.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12 month low of $246.99 and a 12 month high of $698.67.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of recent analyst reports. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. The Goldman Sachs Group increased their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Northland Securities raised their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.